Enlivex Therapeutics Ltd ENLV
NAS: ENLV | ISIN: IL0011319527 30/04/2025
1,020 USD (-2,45%)
(-2,45%)
30/04/2025
Profiel Enlivex Therapeutics Ltd
CEO: Dror Mevorach
Werknemers: 36